rs2276579

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_139343.3(BIN1):​c.957C>T​(p.Ala319Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 1,576,122 control chromosomes in the GnomAD database, including 28,068 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A319A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.14 ( 2027 hom., cov: 32)
Exomes 𝑓: 0.19 ( 26041 hom. )

Consequence

BIN1
NM_139343.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.500

Publications

12 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • centronuclear myopathy
    Inheritance: AD, AR, SD Classification: DEFINITIVE, LIMITED Submitted by: ClinGen
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 2-127059056-G-A is Benign according to our data. Variant chr2-127059056-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.5 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.198 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139343.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
NM_139343.3
MANE Select
c.957C>Tp.Ala319Ala
synonymous
Exon 11 of 19NP_647593.1O00499-1
BIN1
NM_001320642.1
c.876C>Tp.Ala292Ala
synonymous
Exon 11 of 19NP_001307571.1O00499
BIN1
NM_001320641.2
c.864C>Tp.Ala288Ala
synonymous
Exon 10 of 18NP_001307570.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
ENST00000316724.10
TSL:1 MANE Select
c.957C>Tp.Ala319Ala
synonymous
Exon 11 of 19ENSP00000316779.5O00499-1
BIN1
ENST00000357970.7
TSL:1
c.957C>Tp.Ala319Ala
synonymous
Exon 11 of 18ENSP00000350654.3O00499-5
BIN1
ENST00000346226.7
TSL:1
c.864C>Tp.Ala288Ala
synonymous
Exon 10 of 16ENSP00000315411.3O00499-2

Frequencies

GnomAD3 genomes
AF:
0.143
AC:
21798
AN:
151992
Hom.:
2018
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0375
Gnomad AMI
AF:
0.294
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.0482
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.144
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.201
Gnomad OTH
AF:
0.174
GnomAD2 exomes
AF:
0.162
AC:
30419
AN:
188192
AF XY:
0.163
show subpopulations
Gnomad AFR exome
AF:
0.0350
Gnomad AMR exome
AF:
0.163
Gnomad ASJ exome
AF:
0.195
Gnomad EAS exome
AF:
0.0597
Gnomad FIN exome
AF:
0.156
Gnomad NFE exome
AF:
0.207
Gnomad OTH exome
AF:
0.186
GnomAD4 exome
AF:
0.186
AC:
264790
AN:
1424012
Hom.:
26041
Cov.:
38
AF XY:
0.185
AC XY:
130316
AN XY:
704654
show subpopulations
African (AFR)
AF:
0.0306
AC:
1008
AN:
32890
American (AMR)
AF:
0.166
AC:
6443
AN:
38724
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
4898
AN:
25412
East Asian (EAS)
AF:
0.0385
AC:
1465
AN:
38100
South Asian (SAS)
AF:
0.115
AC:
9359
AN:
81158
European-Finnish (FIN)
AF:
0.161
AC:
8051
AN:
49884
Middle Eastern (MID)
AF:
0.185
AC:
1054
AN:
5712
European-Non Finnish (NFE)
AF:
0.203
AC:
222108
AN:
1093140
Other (OTH)
AF:
0.176
AC:
10404
AN:
58992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
13846
27692
41539
55385
69231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7652
15304
22956
30608
38260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.143
AC:
21822
AN:
152110
Hom.:
2027
Cov.:
32
AF XY:
0.141
AC XY:
10502
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.0374
AC:
1552
AN:
41520
American (AMR)
AF:
0.191
AC:
2922
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
716
AN:
3470
East Asian (EAS)
AF:
0.0483
AC:
248
AN:
5134
South Asian (SAS)
AF:
0.108
AC:
522
AN:
4816
European-Finnish (FIN)
AF:
0.144
AC:
1526
AN:
10608
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.201
AC:
13655
AN:
67954
Other (OTH)
AF:
0.176
AC:
371
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
933
1866
2798
3731
4664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
759
Bravo
AF:
0.143
Asia WGS
AF:
0.0940
AC:
326
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
Myopathy, centronuclear, 2 (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
5.5
DANN
Benign
0.48
PhyloP100
0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276579; hg19: chr2-127816632; COSMIC: COSV52118503; COSMIC: COSV52118503; API